• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-XL
Medical Device Problem Codes Inadequacy of Device Shape and/or Size (1583); No Apparent Adverse Event (3189)
Health Effect - Clinical Codes Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/29/2024
Type of Reportable Event Serious Injury
Event or Problem Description
The manufacturer became aware of this event through device tracking department.Based on the information on patient implant form, patient has received two perceval plus aortic valves (pvf-l and pvf-xl) on (b)(6) 2024.Based on the further information received, pvf-l was implanted in the patient and pvf-xl was not used.No further information is available at this time.
 
Event or Problem Description
The manufacturer became aware of this event through device tracking department.Based on the information on patient implant form, patient has received two perceval plus aortic valves (pvf-l and pvf-xl) on (b)(6) 2024.Based on the further information received, pvf-l was implanted in the patient and pvf-xl was not used.Reportedly, patient was sized in between l and xl, both valves were opened, and ultimately pvf-l was chosen to be implanted.As reported, there was no significant delay in the procedure and no malfunction with the devices were noted.
 
Additional Manufacturer Narrative
Updated fields: b4, b5, g3, g6, h2, h6.The manufacturing and material records for the device involved in this event, as they pertain to the reported issue, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this prosthesis satisfied all required material, visual, and performance standards at the time of manufacture and release.Based on the information available, patient was sized in between l and xl, both valves were opened, and ultimately pvf-l was chosen to be implanted.It was also reported that no malfunction with the device was noted.Furthermore, from the document review performed, no manufacturing deficiencies were noted.As such, the event was not related to the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC VALVE
Common Device Name
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key20080157
Report Number3004478276-2024-00161
Device Sequence Number7661780
Product Code LWR
UDI-Device Identifier00896208000825
UDI-Public(01)00896208000825(240)PVF-XL(17)280217
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P150011S013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPVF-XL
Device Catalogue NumberPVF-XL
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/29/2024
Supplement Date Received by Manufacturer08/28/2024
Initial Report FDA Received Date08/27/2024
Supplement Report FDA Received Date09/27/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/16/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age87 YR
Patient SexMale
-
-